PT - JOURNAL ARTICLE AU - Hassler, Eva M. AU - Reishofer, Gernot AU - Köfeler, Harald AU - Renner, Wilfried AU - Hannes, Deutschmann H AU - Mangge, Harald AU - Herrmann, Markus AU - Leber, Stefan L. AU - Gunzer, Felix AU - Almer, Gunter TI - Thigh muscle mass is associated with circulating valeric acid in healthy male volunteers AID - 10.1101/2023.08.11.23293978 DP - 2023 Jan 01 TA - medRxiv PG - 2023.08.11.23293978 4099 - http://medrxiv.org/content/early/2023/08/15/2023.08.11.23293978.short 4100 - http://medrxiv.org/content/early/2023/08/15/2023.08.11.23293978.full AB - Short-chain fatty acids (SCFAs) are circulating metabolites generated by gut microbiota. Recently, a link between age-related muscle loss and gut microbiota has been described, and SCFAs could play a mediating role in this relationship. Acetic, propionic, and butyric acid are the abundant forms and are considered to have health benefits, less is known about valeric and caproic acid.In a cross-sectional study including 155 healthy volunteers, we investigated the relationship between muscle area, as well as intramuscular adipose tissue measured by magnet resonance imaging and circulating SCFAs. SCFAs and additional parameters were measured from serum and sport activities recorded by means of a questionnaire.We found a significant positive association between valeric acid (VA) levels and the thigh cross-sectional muscle area in males. This relationship was independent of age, BMI and weekly training times and was not observed in females. No associations between other SCFAs and the thigh muscle cross-sectional area were observed.To our knowledge, this is the first human study demonstrating a significant relationship between thigh muscle mass and VA, supporting the thesis of the “gut–muscle axis” with VA as a possible interacting player, on the one hand, affected by sex differences, on the other.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe author(s) received no specific funding for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:. This study was approved by the local Ethics Committee of the Medical University Graz (approval num-ber: EK-Nr. 29-585 ex 16/17).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll relevant data are within the manuscript and its Supporting Information files.CAcaproic acid (C6)FFAfree fatty acidsGC-EI/MSgas chromatograph-electron impact-mass spectrometerIMATintramuscular adipose tissueMAmuscle areaMRImagnet resonance imagingMTBEmethyl tert-butyl etherSCFAshort-chain fatty acidsSMAspinal muscular atrophySMNsurvival motoneuronVAvaleric acid (C5)